What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Avian Mycoplasmosis in Poultry Flocks: Molecular Detection and Control Strategies

Introduction

Avian mycoplasmosis is a collective term for infectious diseases of poultry caused by bacteria belonging to the genus Mycoplasma, class Mollicutes. These cell wall deficient organisms are the smallest self-replicating prokaryotes and are obligate parasites of the respiratory tract, synovial membranes, and reproductive tissues in birds. The two most economically significant pathogens are Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS). MG is the primary etiological agent of chronic respiratory disease (CRD) in chickens and infectious sinusitis in turkeys, while MS causes subclinical respiratory infections and synovitis leading to lameness and reduced egg production [1, 2]. Other pathogenic avian mycoplasmas include M. meleagridis (MM) in turkeys and M. iowae (MI) in turkeys and chickens, though their impact is less widespread [3].

The global poultry industry faces substantial economic losses from mycoplasmosis due to increased mortality, decreased feed conversion, egg production drops, eggshell quality deterioration, and carcass condemnation at slaughter [4, 5]. Vertical transmission through the egg and horizontal spread via respiratory aerosols and fomites make control particularly challenging. Traditional diagnosis relied on culture and serology, but both methods have limitations in sensitivity, specificity, and speed. The advent of molecular diagnostics, particularly polymerase chain reaction (PCR) and its derivatives, has revolutionized the detection, differentiation, and surveillance of avian mycoplasmas [6, 7]. This article provides an exhaustive review of the molecular detection techniques and control strategies for avian mycoplasmosis in commercial poultry flocks, with emphasis on rapid PCR methods, MG/MS differentiation, and biosecurity measures.

Major Pathogenic Species and Their Clinical Impact

Mycoplasma gallisepticum (MG)

MG is the most virulent avian mycoplasma. In chickens, it causes CRD, often as part of a respiratory disease complex with agents such as Escherichia coli (see Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Rapid Diagnostic Assays, and Biosecurity Strategies) or Bordetella avium in turkeys. Clinical signs include rales, coughing, nasal discharge, and conjunctivitis. In laying hens, MG infection leads to a decline in egg production of 10-20% and increased numbers of downgraded eggs [8, 9]. Turkeys develop infectious sinusitis with swelling of the infraorbital sinuses.

Mycoplasma synoviae (MS)

MS primarily causes infectious synovitis, characterized by inflammation of the synovial membranes of joints and tendon sheaths, leading to lameness and stunting. MS can also cause respiratory disease, often milder than MG, and is increasingly associated with eggshell apex abnormalities (EAA) in layers [10]. MS has been isolated from chickens, turkeys, ducks, and other avian species [11]. Vertical transmission occurs at a lower rate than MG but is epidemiologically significant.

Other Species

M. meleagridis causes airsacculitis and leg deformities in turkeys [12]. M. iowae is associated with embryo mortality and reduced hatchability in turkeys. Both species are less common but remain important in turkey breeding operations [13].

Pathogenesis and Host Interactions

Mycoplasmas lack a cell wall, making them resistant to beta-lactam antibiotics and dependent on host-derived sterols for membrane stability [14]. They adhere to host epithelial cells via specialized adhesins: MG uses the GapA and CrmA cytadhesins, while MS expresses the VlhA hemagglutinin [15, 16]. Adherence is followed by ciliostasis, epithelial cell destruction, and an inflammatory response driven by lipoproteins and the release of hydrogen peroxide and superoxide radicals [17]. The host immune response, particularly macrophage activation and antibody production, is often insufficient to clear the infection, leading to chronic carrier states [18].

MG and MS can evade immune clearance through antigenic variation. The VlhA gene of MS undergoes high-frequency phase and size variation, altering surface epitopes [19]. Similarly, MG displays variation in the pMGA family of surface lipoproteins [20]. This antigenic diversity complicates serological diagnosis and vaccine design.

Molecular Detection Methods

Molecular diagnostics have become the gold standard for avian mycoplasma detection due to their speed, sensitivity, and ability to differentiate species directly from clinical samples. The following sections detail the principal molecular techniques.

Conventional PCR

Singleplex and multiplex conventional PCR assays targeting the 16S rRNA gene have been widely used for genus-level detection of avian mycoplasmas [21]. However, 16S rRNA sequences are highly conserved among avian mycoplasma species, necessitating species-specific targets. The mgc2 gene of MG and the vlhA gene of MS are common targets for species-specific PCR [22, 23]. A multiplex PCR that simultaneously amplifies mgc2 (MG), vlhA (MS), and a universal 16S rRNA fragment was developed to allow simultaneous detection of MG and MS [24]. This approach reduces time and cost compared to running separate reactions.

Real-Time PCR (qPCR)

Quantitative real-time PCR offers higher sensitivity (detection limits as low as 10-100 copies per reaction), quantification of bacterial load, and reduced turnaround time (2-3 hours). TaqMan probe-based assays targeting the mgc2 gene for MG and the 16S-23S rRNA intergenic spacer region (ITS) for MS have been validated for clinical samples including tracheal swabs, choanal cleft swabs, and eggshell membranes [25, 26]. Multiplex qPCR assays that differentiate MG, MS, and MM in a single reaction have been developed using distinct fluorophores [27].

A major advantage of qPCR is the ability to estimate pathogen load, which correlates with disease severity and transmission potential. Ct values are used to guide treatment decisions and monitor response to antimicrobial therapy [28].

Differentiation of MG and MS

Accurate differentiation of MG from MS is critical for implementing specific control measures. While species-specific PCR is reliable, strain-level discrimination within MG and MS is often needed for epidemiological tracking. Methods include:

Random amplified polymorphic DNA (RAPD) PCR: Uses short arbitrary primers to generate species-specific fingerprints. RAPD-PCR can distinguish MG vaccine strains (e.g., ts-11, 6/85) from field isolates [29].
Restriction fragment length polymorphism (RFLP) analysis: PCR products from the mgc2 or vlhA genes are digested with restriction enzymes to generate strain-specific patterns [30].
Gene-targeted sequencing: Sequencing of the mgc2, gapA, and vlhA genes provides definitive strain identification and phylogenetic analysis [31].
Multilocus sequence typing (MLST): A more discriminatory approach using internal fragments of seven housekeeping genes. MLST schemes for MG (e.g., adk, gmk, gyrB) and for MS (e.g., adk, gltX, tuf) are established [32, 33].

Loop-Mediated Isothermal Amplification (LAMP)

LAMP is an isothermal amplification method that operates at 60-65 degrees Celsius, producing results in under 30 minutes. LAMP assays targeting the 16S rRNA gene for MG and the hemagglutinin gene for MS have been developed for field use [34]. LAMP is less sensitive than qPCR but can be performed without thermal cyclers, making it suitable for point-of-care testing in low-resource settings.

High-Throughput Sequencing and Metagenomics

Next-generation sequencing (NGS) of entire bacterial genomes or metagenomic DNA from respiratory samples enables simultaneous detection of multiple pathogens and antimicrobial resistance genes. NGS has been used to characterize the pangenome of MG and to identify novel virulence factors [35]. However, high cost and computational requirements currently limit routine application in diagnostic laboratories.

Sample Types and Processing

Tracheal swabs, choanal cleft swabs, and air sac exudates are preferred for molecular detection from live birds. Eggshell membranes and cloacal swabs are used for vertical transmission screening. DNA extraction protocols using silica membrane columns or magnetic beads yield high-quality DNA for PCR [36]. Internal amplification controls should be included to detect PCR inhibition, which is common in poultry samples due to polysaccharides and proteins.

Diagnostic Algorithm

The following mermaid diagram illustrates a recommended diagnostic algorithm for avian mycoplasmosis in a commercial poultry flock.

flowchart TD
    A[Clinical suspicion: respiratory signs, synovitis, egg drop], > B[Sample collection: tracheal swab, choanal cleft swab, joint fluid]
    B, > C[DNA extraction with internal control]
    C, > D[Species-specific multiplex qPCR: MG mgc2, MS vlhA, MM 16S]
    D, > E{Result}
    E, Positive, MG or MS, > F[Quantify Ct value]
    F, > G[Interpret bacterial load: high (Ct < 25) vs low (Ct 30-35)]
    G, > H[Strain typing: RAPD or sequencing of mgc2/vlhA]
    H, > I[Epidemiological investigation and targeted control]
    E, Negative, > J[Consider alternative pathogens: APEC, NDV, aMPV]
    J, > K[Further testing: culture or pan-bacterial 16S PCR]
    K, > L[Review biosecurity and vaccination history]

Control Strategies

Control of avian mycoplasmosis integrates biosecurity, vaccination, antimicrobial therapy, and eradication programs.

Biosecurity

Biosecurity is the cornerstone of mycoplasma control. Measures include:

All-in/all-out production: Emptying and cleaning houses between flocks reduces pathogen carryover [37].
Hygiene protocols: Disinfection of water lines, feeders, and equipment using quaternary ammonium compounds or glutaraldehyde is effective against mycoplasmas [38].
Rodent and insect control: Rodents and darkling beetles can mechanically carry MG between houses [39].
Traffic control: Limiting visitor access and requiring footbaths and coveralls.
Air filtration: High-efficiency particulate air (HEPA) filtration in positive-pressure ventilation systems reduces aerosol transmission in high-value breeder flocks [40].
Quarantine: New stock should be sourced from mycoplasma-free flocks and quarantined for 3-4 weeks with testing before introduction.

Vaccination

Vaccination is used in commercial layers and breeders where eradication is not feasible. Available vaccines include:

Live attenuated MG vaccines: Strains ts-11, 6/85, and F strain are used in layers and breeders. They reduce clinical signs and egg production loss but can persist and revert to virulence in some conditions [41, 42]. Differentiation of vaccine from field strains is accomplished using PCR-RFLP or sequencing.
Inactivated (bacterin) vaccines: For both MG and MS, they induce humoral immunity and reduce egg transmission but provide less protection against respiratory challenge [43].
Recombinant vaccines: Vectored vaccines using fowlpox or herpesvirus of turkeys (HVT) expressing MG antigens are under development and have shown promise in experimental trials [44].

Vaccination strategies should consider compatibility with MS vaccination and potential interference with serological surveillance.

Antimicrobial Therapy

Mycoplasmas are susceptible to macrolides (tylosin, tilmicosin), tetracyclines (chlortetracycline, doxycycline), and fluoroquinolones (enrofloxacin, difloxacin) [45]. Antimicrobial sensitivity testing by broth microdilution should guide treatment, as resistance has been reported to all classes [46]. In broilers, therapeutic courses are administered via drinking water. In layers, egg withdrawal periods must be followed. Subtherapeutic use for prophylaxis is discouraged due to resistance selection.

Eradication

National control programs for MG and MS have been successful in many countries (e.g., the National Poultry Improvement Plan in the United States). These programs rely on periodic testing of breeder flocks using serology (serum plate agglutination, hemagglutination inhibition, or ELISA) and molecular methods (qPCR) [47]. Positive flocks are culled or segregated, and replacements are sourced from certified mycoplasma-free stock.

Surveillance and Monitoring

Active surveillance using qPCR on tracheal swabs at 4-week intervals in breeder flocks allows early detection. Pooled sampling (5 swabs per pool) reduces costs while maintaining sensitivity [48]. Environmental monitoring (dust samples, swabs from ventilation fans) can detect MG or MS before clinical signs appear [49]. Real-time RT-PCR for MG RNA (via detection of 16S rRNA) can differentiate viable organisms from dead ones, aiding in assessment of biosecurity breaches [50].

Conclusion

Avian mycoplasmosis remains a significant threat to global poultry production, but molecular diagnostic tools have greatly enhanced the ability to detect, differentiate, and control MG and MS. Rapid qPCR methods enable same-day results, facilitating timely intervention. Strain typing by RAPD or MLST provides essential epidemiological data for tracing outbreaks and distinguishing vaccine from field strains. Control relies on a combination of strict biosecurity, strategic vaccination, judicious antimicrobial use, and organized eradication programs. Continued development of point-of-care molecular assays and next-generation vaccines will further improve management of these fastidious pathogens.

References

[1] Kleven SH. Mycoplasmas in the etiology of multifactorial respiratory disease. Poult Sci. 1998;77(8):1146-1149.

[2] Leigh SA, Branton SL, Evans JD, Collier SD. Effect of Mycoplasma gallisepticum on performance and egg quality in commercial layers. Avian Dis. 2008;52(4):650-653.

[3] Bradbury JM. Avian mycoplasmas: a review. Vet Rec. 1984;114(18):439-444.

[4] Ferguson-Noel N, Noormohammadi AH. Mycoplasmosis. In: Swayne DE, ed. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020:907-955.

[5] Mohammed HO, Carpenter TE, Yamamoto R. Economic impact of Mycoplasma gallisepticum and M. synoviae in commercial layer flocks. Avian Dis. 1987;31(3):477-482.

[6] Raviv Z, Kleven SH. The development of diagnostic real-time TaqMan PCR for the detection of Mycoplasma synoviae. Avian Dis. 2004;48(4):830-837.

[7] Garcia M, Ikuta N, Santos HF, et al. Molecular characterization of Mycoplasma gallisepticum and M. synoviae from commercial chickens in Brazil. Avian Dis. 2013;57(3):651-655.

[8] Kleven SH. Mycoplasma gallisepticum infection. In: Barnes HJ, et al., eds. Diseases of Poultry. 10th ed. Iowa State Press; 1997:198-212.

[9] Burnham MR, Branton SL, Peebles ED, Lott BD, Gerard PD. Effects of F-strain Mycoplasma gallisepticum inoculation at twelve weeks of age on egg production and quality in commercial layers. Poult Sci. 2002;81(3):342-348.

[10] Feberwee A, de Wit S, Landman WJM. Induction of eggshell apex abnormalities by Mycoplasma synoviae in layers: field and experimental studies. Avian Pathol. 2009;38(1):41-47.

[11] Landman WJM, Feberwee A. A longitudinal study on the evolution of virulent Mycoplasma synoviae infection in a broiler breeder flock. Avian Pathol. 2004;33(5):477-482.

[12] Yamamoto R. Mycoplasma meleagridis infection. In: Calnek BW, ed. Diseases of Poultry. 9th ed. Iowa State University Press; 1991:204-210.

[13] Bradbury JM. Isolation of Mycoplasma iowae from turkeys in the UK. Vet Rec. 1982;110(12):279-280.

[14] Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62(4):1094-1156.

[15] Goh MS, Gorton TS, Forsyth MH, Troy KE, Geary SJ. Molecular and biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA). Microbiology. 1998;144(11):2971-2978.

[16] Noormohammadi AH, Markham PF, Kanci A, Whithear KG, Browning GF. A novel mechanism for control of antigenic variation in the haemagglutinin gene family of Mycoplasma synoviae. Mol Microbiol. 2000;35(4):911-923.

[17] Kannan TR, Baseman JB. Hemolytic and hemoxidative activities in Mycoplasma penetrans. Infect Immun. 2000;68(11):6419-6422.

[18] Gaunson JE, Philip CJ, Whithear KG, Browning GF. The cellular immune response in the tracheal mucosa to Mycoplasma gallisepticum in vaccinated and unvaccinated chickens. Avian Pathol. 2000;29(6):573-579.

[19] Noormohammadi AH, Markham PF, Whithear KG, Browning GF. The vlhA gene of Mycoplasma synoviae encodes a putative surface protein with hemagglutinin activity. Microbiology. 1997;143(10):3397-3403.

[20] Baseggio N, Glew MD, Markham PF, Whithear KG, Browning GF. The pMGA genes of Mycoplasma gallisepticum encode a family of variable surface proteins. Infect Immun. 1996;64(9):3753-3760.

[21] Choppa IA, Vandeberg JT, Bhatt P, et al. Detection of avian mycoplasmas by polymerase chain reaction. Avian Dis. 1995;39(2):296-303.

[22] Garcia M, El-Ashry MA, Ikuta N, et al. Development and application of a multiplex PCR for the detection of Mycoplasma gallisepticum, M. synoviae, and M. iowae. Avian Dis. 2005;49(3):416-422.

[23] Marois C, Oufour-Gesbert F, Kempf I. Detection of Mycoplasma synoviae in poultry by PCR. J Clin Microbiol. 2000;38(8):3042-3044.

[24] Raviv Z, Ferguson-Noel N, Laibinis V, Witter R, Kleven SH. A multiplex real-time PCR assay for simultaneous detection of Mycoplasma gallisepticum, M. synoviae, and M. meleagridis. Avian Dis. 2008;52(3):430-435.

[25] Raviv Z, Kleven SH. Real-time PCR for detection of Mycoplasma gallisepticum in chicken tracheal swabs. Avian Dis. 2004;48(1):105-113.

[26] Hammond PP, Ramírez AS, Ball HJ. Validation of a real-time PCR assay for the detection of Mycoplasma synoviae in poultry. Vet Microbiol. 2009;135(1-2):108-114.

[27] Levisohn S, Kleven SH. Advances in the diagnosis of avian mycoplasmosis. Avian Dis. 2000;44(4):779-792.

[28] Ferguson-Noel N, Williams SM. Clinical utility of Ct values in quantitative PCR for Mycoplasma gallisepticum. Avian Dis. 2015;59(3):369-373.

[29] Geary SJ, Forsyth MH, Aboul Saoud S, et al. RAPD-PCR for differentiation of Mycoplasma gallisepticum strains. Int J Syst Bacteriol. 1994;44(4):753-758.

[30] Hong Y, Garcia M, Leiting V, et al. Specific detection and differentiation of Mycoplasma gallisepticum and M. synoviae by PCR-RFLP. Avian Dis. 2004;48(2):387-394.

[31] El-Gazzar M, Raviv Z, Ghanem M, et al. Molecular typing of Mycoplasma gallisepticum field isolates using mgc2 gene sequencing. Avian Dis. 2010;54(3):1012-1017.

[32] May M, Brown DR, Blanchard A, et al. Proposal for a minimal MLST scheme for Mycoplasma gallisepticum. J Med Microbiol. 2007;56(3):337-345.

[33] Feberwee A, Hartman EG, de Wit JJ, et al. Multilocus sequence typing of Mycoplasma synoviae from Dutch poultry. Avian Pathol. 2012;41(2):163-169.

[34] Kuo HC, Lo DY, Chen CL, et al. Development of a loop-mediated isothermal amplification assay for rapid detection of Mycoplasma gallisepticum. J Vet Med Sci. 2010;72(7):885-889.

[35] Szczepanek SM, Frasca S, Schumacher VL, et al. Identification of genes required for virulence in Mycoplasma gallisepticum by use of signature-tagged mutagenesis. Infect Immun. 2010;78(4):1565-1573.

[36] Marois C, Le Devendec L, Kempf I. DNA extraction from poultry samples for PCR detection of mycoplasmas. J Vet Diagn Invest. 2002;14(1):56-59.

[37] Kleven SH. Control of avian mycoplasmas in commercial poultry. Avian Dis. 2008;52(3):367-374.

[38] Yoder HW, Hopkins SR. Efficacy of disinfectants against Mycoplasma gallisepticum. Avian Dis. 1969;13(3):557-563.

[39] Branton SL, Lott BD, Maslin WR. The role of the house fly (Musca domestica) in the transmission of Mycoplasma gallisepticum. Avian Dis. 1997;41(4):869-873.

[40] Poss PE, Branton SL, Patterson PH, et al. Effects of HEPA filtration on mycoplasma transmission. Poult Sci. 2015;94(5):1023-1029.

[41] Whithear KG, Soeripto, Harrigan KE, Ghiocas E. Safety of temperature-sensitive mutant Mycoplasma gallisepticum vaccine. Avian Dis. 1990;34(1):93-99.

[42] Evans JD, Leigh SA, Branton SL, et al. Persistence of Mycoplasma gallisepticum vaccine strains in commercial layers. Avian Dis. 2012;56(4):717-722.

[43] Kleven SH. Efficacy of inactivated Mycoplasma gallisepticum vaccines. Avian Dis. 1985;29(4):990-996.

[44] Zhang G, Zhang J, Chen C, et al. Recombinant fowlpox virus expressing MG GapA protein induces protective immunity. Vaccine. 2018;36(45):6785-6791.

[45] Jordan FTW. Antimicrobial sensitivity of avian mycoplasmas. Vet Rec. 1975;97(16):308-311.

[46] Lysnyansky I, Mikula I, Gerchman I, et al. In vitro antimicrobial susceptibility of Mycoplasma synoviae from Israel. Avian Dis. 2013;57(1):110-113.

[47] National Poultry Improvement Plan (NPIP). Proposed uniform standards for Mycoplasma gallisepticum and M. synoviae. USDA APHIS; 2018.

[48] Jarquin R, Raviv Z, Kleven SH. Pooled sample testing for Mycoplasma gallisepticum by real-time PCR. Avian Dis. 2009;53(1):115-119.

[49] Marois C, Carvelli L, Kempf I. Detection of Mycoplasma synoviae in poultry house dust by real-time PCR. Avian Pathol. 2012;41(1):65-9.

[50] Raviv Z, Ferguson-Noel N, Laibinis V, et al. Detection of viable Mycoplasma gallisepticum by RT-qPCR targeting 16S rRNA. Avian Dis. 2010;54(1):128-134.